Back to Markets

GILD vs LLY

A side-by-side look at GILD and LLY, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

GILD vs LLY: how they differ

Gilead Sciences, Inc. (GILD) and Eli Lilly and Company (LLY) are both in the Healthcare sector, in the same Drug Manufacturers - General industry. GILD trades on NASDAQ and LLY on NYSE.

GILD trades about 6.6 million shares a day on average, against 2.6 million for LLY. LLY has the higher beta (0.45 against 0.33 for GILD), meaning it has historically moved more with the broad market. Over the trailing twelve months, GILD paid $3.25 per share in dividends and LLY paid $6.69 per share.

Figures as of October 25, 2026.

More comparisons

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.